Eli Lilly has announced plans to acquire Scorpion Therapeutics’ PI3Kα inhibitor program. Credit: Michael Vi via Shutterstock. Eli Lilly will buy Boston biotech Scorpion Therapeutics’ PI3Kα inhibitor ...

MEMPHIS, Tenn. (AP) — Sentencings for five former Memphis police officers convicted of federal charges in the beating death of Tyre Nichols will take place after an April state court trial on ...

Meanwhile, Lilly announced plans to acquire Scorpion Therapeutics’ PI3Kα inhibitor STX-478 for $2.5 billion, with its non-PI3Kα drugs spun off into a new company. STX-478 is currently in Phase I ...

If you're planning a trip to Belize, the U.S. government might want you to reconsider. According to the U.S. Department of State, Belize is currently under a level 2 travel advisory while Belize ...

South Brunswick sank 3-pointers on six of its first seven field goals en route to beating North Brunswick 61-39 in the Mideastern 3A/4A Conference girls basketball game Monday at South. The victory ...

GALVESTON, Texas — Planning on taking a cruise to Belize anytime soon? The U.S. State Department is urging Americans to exercise increased caution. The State Department issued a Level 2 travel ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...